GlassScriptPhysician profile
Shachi Pandya
NPI 1164817334
$2,993.27
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.69 · 2020: $949 · 2021: $1,257 · 2022: $702.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $736.40 | 2020-2022 | |
| Novo Nordisk INC | $479.68 | 2019-2022 | |
| Pfizer INC. | $264.08 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $209.45 | 2019-2022 | |
| Glaxosmithkline, LLC. | $183.18 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $170.82 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $167.66 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.28 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $115.91 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.96 | 2022 | |
| Horizon Therapeutics Plc | $93.23 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $70.06 | 2021 | |
| Medtronic, INC. | $53.09 | 2021 | |
| Merck Sharp & Dohme LLC | $39.21 | 2022 | |
| Dexcom, INC. | $39.05 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $32.72 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $23.05 | 2019-2022 | |
| Genentech USA, INC. | $16.36 | 2021 | |
| Amarin Pharma, INC. | $14.08 | 2021 | |
| Phadia US INC. | $13.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shachi Pandya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.